Showing results (941-950 of 952) with videos related to
Sort By:
Pageof 96
The New England Journal of Medicine|March 25, 2026
Transdermal Estradiol Patches in Locally Advanced Prostate CancerRuth E Langley, Duncan C Gilbert, Stephen Mangar, et al.The Lancet. Oncology|July 10, 2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocolSilke Gillessen, Laura Murphy, Nicholas D James, et al.The New England Journal of Medicine|January 29, 2015
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAKatie Ewer, Tommy Rampling, Navin Venkatraman, et al.The Lancet. HIV|June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trialJohn Frater, Katie J Ewer, Ane Ogbe, et al.JNCI Cancer Spectrum|July 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled TrialNicholas D James, Fiona C Ingleby, Noel W Clarke, et al.JCI Insight|February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIVAne Ogbe, Matthew Pace, Mustapha Bittaye, et al.Cell|April 14, 2021
Antibody evasion by the P.1 strain of SARS-CoV-2Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.Cell|July 9, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Helen M Ginn, Wanwisa Dejnirattisai, et al.Lancet (London, England)|April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialKatherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.Lancet (London, England)|November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialMaheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.Pageof 96